Skip to content

A Symptom Cluster Management Program for Postmenopausal Breast Cancer Patients Receiving AIs Based on a Dynamic Symptom Model

Construction and Evaluation of a Symptom Cluster Management Model for Postmenopausal Breast Cancer Patients Receiving Third-Generation Aromatase Inhibitors Based on a Dynamic Symptom Model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108477
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-04
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Intervention group:On the basis of routine care, the symptom cluster management program for AI-related symptoms was implemented for postmenopausal breast cancer patients.
Control group:Routine nursing care for endocrine therapy in breast cancer was provided, including an introduction to the basic knowledge of endocrine therapy and general health education for patients.

Sponsors

Liaoning Cancer Hospital & Insititute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with ER+ and/or PR+ breast cancer with pathological immunohistochemistry results; 2. The pathological stage is I.~III.; 3. Oral third-generation aromatase inhibitors (such as letrozole, anastrozole, exemestane, etc.); 4. Menopausal status; 5. Have complete clinical data; 6. Those who have certain comprehension and language expression skills and are willing to participate in this study

Exclusion criteria

Exclusion criteria: 1. Patients with serious impairment of the function of other important organs (such as liver, lungs, kidneys) or a history of other malignant tumors; 2. Patients with rheumatoid arthritis; 3. Recurrence or recurrence of breast cancer during treatment

Design outcomes

Primary

MeasureTime frame
Quality of life (QoL);

Secondary

MeasureTime frame
Symptom management self-efficacy;

Countries

China

Contacts

Public ContactXu Hui

Liaoning Cancer Hospital &Institute

xuhui@cmu.edu.cn+86 189 0091 7737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026